Karen L. Tubridy, Chief Development Officer at Eleven Biotherapeutics, Inc. (EBIO), sold 4,427 shares at $2.85 ($13K) on 2015-12-28, disclosed to the SEC on 2015-12-30.
Open-market sale of $13k EBIO by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |